Concepedia

MASATOMO FUKASAWA

MF

14

Publications

605

Citations

11

H-Index

1983

Active since

Affiliations

Sumitomo Dainippon Pharma (Japan)(Current)

Sumitomo Dainippon Pharma (United States)

MASATOMO FUKASAWA is an author at Sumitomo Dainippon Pharma (Japan) specializing in drug resistance, antimicrobial resistance, and clinical microbiology.

Top concepts

Publications per year

1983–1996

14

Publications

14

A novel carbapenem antibiotic, SM-7338 structure-activity relationships.

Makoto Sunagawa, HARUKI MATSUMURA, TAKAAKI INOUE et al. · The Journal of Antibiotics · 1990 · 179 citations · Full text

Stability of meropenem and effect of 1 beta-methyl substitution on its stability in the presence of renal dehydropeptidase I

MASATOMO FUKASAWA, Yoshihiro Sumita, E.T. Harabe et al. · Antimicrobial Agents and Chemotherapy · 1992 · 130 citations · Full text

, , +11

Comparison of two carbapenems, SM-7338 and imipenem. Affinities for penicillin-binding proteins and morphological changes.

Yoshihiro Sumita, MASATOMO FUKASAWA, Takao Okuda · The Journal of Antibiotics · 1990 · 77 citations · Full text

Meropenem Resistance in <i>Pseudomonas aeruginosa</i>

Yoshihiro Sumita, MASATOMO FUKASAWA · Chemotherapy · 1996 · 37 citations

Antimicrobial activity of SM-17466, a novel carbapenem antibiotic with potent activity against methicillin-resistant Staphylococcus aureus

Yoshihiro Sumita, HIROSHI NOUDA, Katsunori Kanazawa et al. · Antimicrobial Agents and Chemotherapy · 1995 · 36 citations · Full text

, , +16

Rows per page

1–5 of 14